From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229
Update: 2024-02-28
Description
Join us as we talk to Nicole Sandford, CEO of Aspira Women’s Health. Aspira Women’s Health is a publicly traded women’s health diagnostics company whose suite of non-invasive ovarian cancer blood tests are helping ensure women receive the best care. Nicole has an extensive background as a highly skilled operator and took the helm at Aspira in early 2022.
In their conversation, Nicole and Brittany discuss the challenges unique to ovarian cancer detection and treatment, why Aspira’s products are so revolutionary, and how the company is going after endometriosis next.
Remember to like, rate and subscribe and enjoy the episode!
In their conversation, Nicole and Brittany discuss the challenges unique to ovarian cancer detection and treatment, why Aspira’s products are so revolutionary, and how the company is going after endometriosis next.
Remember to like, rate and subscribe and enjoy the episode!
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
